- Schizophrenia and schizoaffective disorders were associated with lower odds of receiving second-generation LAIs than bipolar spectrum disorders.
- Any substance use predicted higher odds of second-generation LAI receipt, while additional discharge psychotropics predicted lower odds.
- Among SGA recipients, stimulant use was linked to lower odds of paliperidone versus aripiprazole; longer hospitalisation, additional psychotropics and older age increased paliperidone odds.
Int Clin Psychopharmacol. 2026 Nov 17. doi: 10.1097/YIC.0000000000000643. Online ahead of print.
ABSTRACT
Factors associated with receipt of different long-acting injectable antipsychotics (LAIs) remain incompletely understood. This retrospective study examined 370 psychiatric inpatients receiving LAIs between January 2020 and October 2022. Logistic regression compared first-generation (FGA) versus second-generation (SGA) LAI receipt and paliperidone palmitate versus aripiprazole lauroxil receipt. Fixed-covariate sensitivity analyses excluded inpatient-course variables. Overall, 313 patients received SGA LAIs and 57 received FGA LAIs. In primary models, schizophrenia spectrum and schizoaffective disorders were associated with lower odds of SGA receipt than bipolar spectrum disorders. Substance use was associated with higher odds of SGA receipt, whereas additional discharge psychotropics were associated with lower odds. Among SGA recipients, stimulant use was associated with lower odds of paliperidone receipt (adjusted odds ratio: 0.32, 95% confidence interval: 0.17-0.60), while longer hospitalization and additional discharge psychotropics were associated with higher odds. In sensitivity analyses, schizoaffective and stimulant-use associations persisted, schizophrenia spectrum and any-substance-use associations were not statistically significant. Older age was also associated with paliperidone receipt. These exploratory findings describe differences between LAI prescribing groups, without establishing prescribing rationale or comparative effectiveness. Inpatient-course associations require caution because their temporal relationship to medication selection was uncertain.
PMID:43056638 | DOI:10.1097/YIC.0000000000000643
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

